- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine therapies for patients with glioblastoma
Authors
Keywords
Glioma, Glioblastoma, Vaccine, Immunotherapy
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 119, Issue 3, Pages 531-546
Publisher
Springer Nature
Online
2014-08-27
DOI
10.1007/s11060-014-1502-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-
- (2013) G. Kohanbash et al. CANCER RESEARCH
- Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
- (2013) M. Prosniak et al. CLINICAL CANCER RESEARCH
- Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages
- (2013) O. Bloch et al. CLINICAL CANCER RESEARCH
- Vaccine strategies for glioblastoma: progress and future directions
- (2013) Christopher Jackson et al. Immunotherapy
- Constitutive Activation of Signal Transducer and Activator of Transcription 3 (STAT3) and Nuclear Factor κB Signaling in Glioblastoma Cancer Stem Cells Regulates the Notch Pathway
- (2013) Jo Meagan Garner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heat-shock protein peptide complex–96 vaccination for recurrent glioblastoma: a phase II, single-arm trial
- (2013) Orin Bloch et al. NEURO-ONCOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of STAT3 Reduces Astrocytoma Cell Invasion and Constitutive Activation of STAT3 Predicts Poor Prognosis in Human Astrocytoma
- (2013) Qinchuan Liang et al. PLoS One
- Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
- (2013) T. Doucette et al. Cancer Immunology Research
- TGF-β as a therapeutic target in high grade gliomas – Promises and challenges
- (2012) Justin V. Joseph et al. BIOCHEMICAL PHARMACOLOGY
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Impact of the per-operatory application of GLIADEL wafers (BCNU, carmustine) in combination with temozolomide and radiotherapy in patients with glioblastoma multiforme: Efficacy and toxicity
- (2012) Petra Miglierini et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Sequential Immunotherapy by Vaccination With GM-CSF–expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors
- (2012) Pankaj Agarwalla et al. JOURNAL OF IMMUNOTHERAPY
- Natural HLA class I ligands from glioblastoma: extending the options for immunotherapy
- (2012) Marian Christoph Neidert et al. JOURNAL OF NEURO-ONCOLOGY
- Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
- (2012) Shota Tanaka et al. Nature Reviews Clinical Oncology
- Cancer Immunoediting in Malignant Glioma
- (2012) Gavin P. Dunn et al. NEUROSURGERY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma
- (2012) John H. Sampson et al. PLoS One
- Monitoring of Regulatory T Cell Frequencies and Expression of CTLA-4 on T Cells, before and after DC Vaccination, Can Predict Survival in GBM Patients
- (2012) Brendan Fong et al. PLoS One
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response
- (2012) N. J. Szerlip et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Challenges in Immunotherapy Presented by the Glioblastoma Multiforme Microenvironment
- (2011) Christopher Jackson et al. Clinical & Developmental Immunology
- Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas
- (2011) Serena Pellegatta et al. Expert Review of Anticancer Therapy
- Heat shock protein–peptide complex in the treatment of glioblastoma
- (2011) Alfred P See et al. Expert Review of Vaccines
- Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma
- (2011) Yoshihiro Muragaki et al. JOURNAL OF NEUROSURGERY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD91-dependent programming of T-helper cell responses following heat shock protein immunization
- (2011) Sudesh Pawaria et al. Nature Communications
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Overview of Cellular Immunotherapy for Patients with Glioblastoma
- (2010) Elodie Vauleon et al. Clinical & Developmental Immunology
- Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy
- (2010) Robert M. Prins et al. CLINICAL CANCER RESEARCH
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Cellular and vaccine therapeutic approaches for gliomas
- (2010) Michelle J Hickey et al. Journal of Translational Medicine
- The Presence of IL-17A and T Helper 17 Cells in Experimental Mouse Brain Tumors and Human Glioma
- (2010) Derek A. Wainwright et al. PLoS One
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- Glioma Stem Cell Research for the Development of Immunotherapy
- (2009) Jianfei Ji et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Dendritic-cell- and peptide-based vaccination strategies for glioma
- (2009) Ryuya Yamanaka NEUROSURGICAL REVIEW
- Toward effective immunotherapy for the treatment of malignant brain tumors
- (2009) Duane A. Mitchell et al. Neurotherapeutics
- A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
- (2008) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients
- (2008) F. Zeppernick et al. CLINICAL CANCER RESEARCH
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
- Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
- (2008) Joannes F.M. Jacobs et al. NEURO-ONCOLOGY
- Molecular strategies for the treatment of malignant glioma—genes, viruses, and vaccines
- (2008) Lee A. Selznick et al. NEUROSURGICAL REVIEW
- Cell- and peptide-based immunotherapeutic approaches for glioma
- (2008) Ryuya Yamanaka TRENDS IN MOLECULAR MEDICINE
- Heat shock protein derivatives for delivery of antigens to antigen presenting cells
- (2007) Makiya Nishikawa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started